Why the study?
Evidence regarding the best pacing mode for high-degree AV block following TAVI is currently lacking.
Does left bundle branch pacing improve survival and functional capacity compared to right ventricular pacing in patients with high-degree AV block and preserved LVEF post-TAVI?
Does left bundle branch pacing improve survival and functional capacity compared to right ventricular pacing in patients with high-degree AV block and preserved LVEF post-TAVI?
In a pilot RCT of patients with high-degree AV block and preserved LVEF post-TAVI, left bundle branch pacing was feasible and yielded similar midterm clinical outcomes to right ventricular pacing.
LBBP shows no midterm advantage over RV pacing post-TAVI; pilot RCT leaves open superiority in larger trials.
Background: There is currently no evidence of the best pacing mode for high-degree atrioventricular (AV) block occurring after transcatheter aortic valve implantation (TAVI). The objective of this pilot study was to compare a clinical combined endpoint achieved by left bundle branch pacing (LBBP) vs right ventricular (RV) pacing in patients with preserved left ventricular ejection fraction (LVEF) post-TAVI at 12-month follow-up. Methods: Consecutive patients post-TAVI with high-degree AV block and LVEF ≥ 50% were randomized to LBBP or RV pacing. The primary endpoint was survival with an improvement of ≥ 1 point in New York Heart Association functional class or a ≥ 25% increase in distance covered on the 6-minute walking test. Secondary endpoints were change in LVEF, septal flash, mitral regurgitation, N-terminal pro-brain natriuretic peptide, heart failure hospitalization, score on symptoms, and QRS duration. Results: = 0.03). There was no difference between groups on any other endpoint. Conclusions: Similar midterm outcomes were obtained with LBBP and RV pacing in an elderly population with high-degree AV block and preserved LVEF after TAVI. The pilot Phys-TAVI trial showed the feasibility of LBBP in this population. Larger randomized clinical trials with longer follow-up are needed to test for differential clinical outcomes between pacing modalities. Clinical Trial Registration: NCT04482816.
No takes yet. Share an insight, caveat, or question.
Pujol‐López et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: